Market Announcements 2012
10 May 2012 - New Teva Representative Joins Mesoblast Board of Directors- 17 April 2012 - Intervertebral Disc Repair Phase 2 Trial Update
- 26 March 2012 - Mesoblast Presents Program Updates At Credit Suisse 15th Asia Investment Conference
- 27 February 2012 – Half Year Results: Mesoblast Posts Strong Cash Balance
- 9 February 2012 - Change of Company Secretary and Registered Office Address